Dr. Peter Kayatz

Certified Interim Manager with proven achievements in change management, coaching & training, fundraising and financing (public & private), business development, partnering, licensing, as well as in conducting due diligence for venture capital firms. - My experience is your Peace of Mind! Specialties: Business planning, licensing, financing, negotiations between entrepreneurial companies and large multinational companies.

Science4Life is an independent start-up initiative that offers consulting, support and further education for young companies in the life sciences, chemistry and energy sectors throughout Germany free of charge. It was founded in 1998 as a non-profit organization and has been an association since 2003. Initiators and sponsors are the Hessian state government and the health company Sanofi.

gnite is an intensive, one-week training program for aspiring entrepreneurs and corporate innovators to trial and prepare business ideas for the commercial environment. Peter was invited by the program manager of Ignite to contribute in form of one-to-one coachings (expert clinics) and joining the final pitching panel.

Shareholder and Coach

Interim Managing Director of Star-up Company (Ltd) Set up of Organisation Acquisition of Grants and Soft Loans > 1 Mio. € Acquisition of Corporate Venture Capital > 10 Mio. €. - Trade Sale to Sanochemia Pharmazeutika, Vienna, in 2006.

Portfolio management, interim management, venture development, fund raising.

Head of the Competence Center Life Sciences, - Consulting of venture capital firms, venture screen, due diligence, start-up consulting, acquisition of venture capital, interim management

Redesign and setup of organizational structure, workflow management and product development, subsequent to a growth financing by Ventizz Capital Partners, Düsseldorf. - Innovatis was sold to Roche in 2009

Interim Investment Manager Life Sciences- venture screen and evaluation, management presentations, due diligence, investment proposal. - Today, the IMH-Funds are managed by Triginta.

Management of high-tech companies, accounting, financing & valuation, controlling, patenting & licensing

Methods for the descriptive and analytical biostatistics and the interpretation thereof.

Development of the first electron microscopic technique for the ultra structural localization of lipid peroxides. Publication in 'Methods of Enzymology'

Investigations regarding the pathogenesis of AMD (age related macular degeneration), with focus on the processing of peroxidized lipids and proteins in the retina of rats. A total of 11 scientific full papers. There of two first Author Papers in 'Invest Ophtalmol Vis Sci'

'Signal transduction of the insulin receptor – investigation of the autophosphorylation sites of the intra cellular domain of the insulin receptor'

Advanced courses in biochemistry, molecular genetics, organic chemistry, botanic Grants by Bayer AG and Carl-Duisberg-Foundation